Most Emailed Articles

A Randomized Double-Blind Placebo-Controlled Phase III Trial of Selegiline Monotherapy for Early Parkinson Disease

Mizuno, Yoshikuni; Hattori, Nobutaka; Kondo, Tomoyoshi; More

Clinical Neuropharmacology. 40(5):201-207, September/October 2017.